These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15763792)

  • 21. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Submucosal fibroids and the relation to heavy menstrual bleeding and anemia.
    Puri K; Famuyide AO; Erwin PJ; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2014 Jan; 210(1):38.e1-7. PubMed ID: 24080304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
    Thomas EJ
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():18-21. PubMed ID: 8916983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term intermittent pharmacological therapy with ulipristal acetate on reducing the volume of uterine fibroids and relieving symptoms.
    Kyeong HK; Choi J; Na YJ; Kim HG
    Minerva Obstet Gynecol; 2023 Jun; 75(3):236-242. PubMed ID: 36786781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.
    Muhammad J; Yusof Y; Ahmad I; Norhayati MN
    BMC Womens Health; 2022 Jan; 22(1):14. PubMed ID: 35033041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
    Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreasing bleeding due to uterine fibroid with electroacupuncture.
    Cakmak YÖ; Akpınar IN; Yoldemir T; Cavdar S
    Fertil Steril; 2011 Jul; 96(1):e13-5. PubMed ID: 21561613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids.
    Ghonim M; Magdy R; Sabbour M; Ghonim M; Nabhan A
    Int J Gynaecol Obstet; 2019 Aug; 146(2):141-148. PubMed ID: 31127621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: case report.
    Vilos GA; Vilos EC; Romano W; Abu-Rafea B
    Hum Reprod; 2006 Jan; 21(1):269-71. PubMed ID: 16155072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
    Syed YY
    Drugs; 2022 Oct; 82(15):1549-1556. PubMed ID: 36331779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.
    Yun BS; Seong SJ; Jung YW; Kim ML; Bae HS; Kim MK; Shim SS
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():133-136. PubMed ID: 29602142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Ulipristal Acetate Therapy on Uterine Fibroid-Related Symptoms and on Uterine and Fibroid Volumes and Vascularity Indices Assessed by Ultrasound.
    Baggio S; Pomini P; Galeone F; Presti F; Santi L; Raffaelli R; Franchi M
    J Ultrasound Med; 2018 Sep; 37(9):2215-2223. PubMed ID: 29498074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroid management in premenopausal women.
    Donnez J; Courtoy GE; Dolmans MM
    Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
    Pérez-López FR
    Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
    Nooh AM; Abdeldayem HM; Girbash EF; Arafa EM; Atwa K; Abdel-Raouf SM
    Reprod Sci; 2016 Apr; 23(4):448-54. PubMed ID: 26718306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.